tetradecanoylphorbol acetate has been researched along with Complications of Diabetes Mellitus in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bierhaus, A; Bukulin, M; Fahrenholz, F; Kojro, E; Metz, VV; Nawroth, PP; Postina, R; Roth, A; Zhang, L | 1 |
| Collard, E; Roy, S | 1 |
| Djordjevic, V; Ivic, M; Mitic-Zlatkovic, M; Stefanovic, V; Vlahovic, P | 1 |
| Cai, S; Du, J; Ou, X; Ren, X; Zeng, J | 1 |
| Chen, J; Egawhary, DN; Swoboda, BE; Vince, FP | 1 |
5 other study(ies) available for tetradecanoylphorbol acetate and Complications of Diabetes Mellitus
| Article | Year |
|---|---|
Receptor for advanced glycation end products is subjected to protein ectodomain shedding by metalloproteinases.
Topics: ADAM Proteins; ADAM10 Protein; Alternative Splicing; Alzheimer Disease; Amyloid Precursor Protein Secretases; Calcimycin; Carcinogens; Cell Line; Cell Membrane; Diabetes Complications; Humans; Hydroxamic Acids; Ionophores; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Membrane Proteins; Protease Inhibitors; Protein Isoforms; Protein Structure, Tertiary; Receptor for Advanced Glycation End Products; Receptors, Immunologic; RNA, Small Interfering; Tetradecanoylphorbol Acetate | 2008 |
Improved function of diabetic wound-site macrophages and accelerated wound closure in response to oral supplementation of a fermented papaya preparation.
Topics: Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Blood; Blood Glucose; Body Weight; Carica; Diabetes Complications; Diabetes Mellitus; Dietary Supplements; Endothelial Cells; Fermentation; Fruit; Gene Expression; Insulin; Lipids; Lipopolysaccharides; Lipoproteins; Macrophages; Male; Mice; Mice, Obese; Nitric Oxide; Nitric Oxide Synthase Type II; Plant Preparations; Platelet Endothelial Cell Adhesion Molecule-1; Reactive Oxygen Species; Superoxides; Tetradecanoylphorbol Acetate; Vascular Endothelial Growth Factor A; Wound Healing; Wounds and Injuries | 2010 |
Lymphocyte PC-1 activity in patients on maintenance haemodialysis treated with human erythropoietin and 1-alpha-D3.
Topics: Adjuvants, Immunologic; Administration, Oral; Adult; Aged; Blood Glucose; Carcinogens; Concanavalin A; Diabetes Complications; Diabetes Mellitus, Type 2; Erythropoietin; Female; Humans; Hydroxycholecalciferols; Insulin Resistance; Kidney Failure, Chronic; Lymphocyte Activation; Lymphocytes; Male; Middle Aged; Phosphoric Diester Hydrolases; Pyrophosphatases; Recombinant Proteins; Renal Dialysis; Tetradecanoylphorbol Acetate | 2005 |
Methylglyoxal downregulates Raf-1 protein through a ubiquitination-mediated mechanism.
Topics: Cell Culture Techniques; Diabetes Complications; Down-Regulation; Humans; Oxidation-Reduction; Phosphorylation; Proteasome Endopeptidase Complex; Protein Kinase C; Proto-Oncogene Proteins c-raf; Pyruvaldehyde; Signal Transduction; Tetradecanoylphorbol Acetate; Ubiquitin-Activating Enzymes | 2006 |
Diabetic complications and the mechanism of the hyperglycaemia-induced damage to the mt DNA of cultured vascular endothelial cells: (II) The involvement of protein kinase C.
Topics: Cells, Cultured; Diabetes Complications; Diabetes Mellitus; DNA Damage; DNA, Mitochondrial; Endothelium, Vascular; Enzyme Activation; Glycation End Products, Advanced; Humans; Hyperglycemia; Protein Kinase C; Reactive Oxygen Species; Sequence Deletion; Tetradecanoylphorbol Acetate | 1995 |